- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Products (Recombinant protein) | Swiss Prot# | Size | Price (US$) | Order |
PP0933 | Recombinant Protein-Streptococcus agalactiae Cpn60 groEL protein (a.a.61 to 540) | Q9AME7 | 100 µg | 1195 | |
PP0934 | Recombinant Protein-Streptococcus agalactiae C protein alpha antigen (a.a.21 to 145) | Q3CXZ9 | 100 µg | 1195 | |
PP0935 | Recombinant Protein-Streptococcus agalactiae C protein alpha-antigen (a.a.21 to 223) | Q3CZ94 | 100 µg | 1195 | |
PP0936 | Recombinant Protein-Streptococcus agalactiae C protein immunoglobulin-A-binding beta antigen (a.a.21 to 165) | Q49QZ4 | 100 µg | 1195 | |
PP0937 | Recombinant Protein-Streptococcus agalactiae Immunodominant antigen A (a.a.25 to 215) | Q3DC29 | 100 µg | 1195 | |
PP0938 | Recombinant Protein-Streptococcus agalactiae Pneumococcal vaccine antigen A (a.a.27 to 200) | Q3DT67 | 100 µg | 1195 | |
PP0939 | Recombinant Protein-Streptococcus agalactiae 67 kDa myosin-cross-reactive streptococcal antigen (a.a.61 to 361) | Q3K015 | 100 µg | 1195 | |
PP0940 | Recombinant Protein-Streptococcus agalactiae serotype Ia IgA-binding beta antigen (a.a.61 to 460) | Q3K3P4 | 100 µg | 1195 | |
RPP0933 | cDNA-Streptococcus agalactiae Cpn60 groEL protein (a.a.61 to 540) | Q9AME7 | 2 µg | 2395 | |
RPP0934 | cDNA-Streptococcus agalactiae C protein alpha antigen (a.a.21 to 145) | Q3CXZ9 | 2 µg | 800 | |
RPP0935 | cDNA-Streptococcus agalactiae C protein alpha-antigen (a.a.21 to 223) | Q3CZ94 | 2 µg | 1010 | |
RPP0936 | cDNA-Streptococcus agalactiae C protein immunoglobulin-A-binding beta antigen (a.a.21 to 165) | Q49QZ4 | 2 µg | 720 | |
RPP0937 | cDNA-Streptococcus agalactiae Immunodominant antigen A (a.a.25 to 215) | Q3DC29 | 2 µg | 950 | |
RPP0938 | cDNA-Streptococcus agalactiae Pneumococcal vaccine antigen A (a.a.27 to 200) | Q3DT67 | 2 µg | 865 | |
RPP0939 | cDNA-Streptococcus agalactiae 67 kDa myosin-cross-reactive streptococcal antigen (a.a.61 to 361) | Q3K015 | 2 µg | 1500 | |
RPP0940 | cDNA-Streptococcus agalactiae serotype Ia IgA-binding beta antigen (a.a.61 to 460) | Q3K3P4 | 2 µg | 1995 |
Streptococcus agalactiae cDNA and recombinant antigen
Streptococcus agalactiae, also known as group B streptococcus (GBS), is a bacterium that commonly colonizes the human gastrointestinal and genitourinary tracts. While GBS is typically harmless in healthy individuals, it can cause serious infections in vulnerable populations such as newborns, pregnant women, and the elderly.
Streptococcus agalactiae produces the key virulence factors of GBS is its ability to produce a variety of proteins that aid in colonization and evasion of the host immune system. Several of these proteins have been identified and studied in detail, including the Cpn60 groEL protein, C protein alpha antigen, C protein alpha-antigen, C protein immunoglobulin-A-binding beta antigen, Immunodominant antigen A, Pneumococcal vaccine antigen A, 67 kDa myosin-cross-reactive streptococcal antigen, and serotype Ia IgA-binding beta antigen.
Cpn60 groEL protein
The Cpn60 groEL protein is a chaperonin that helps other proteins to fold correctly. It has been shown to be essential for the survival of GBS in host cells and is a promising target for vaccine development.
C protein alpha antigen
The C protein alpha antigen is a surface protein that has been implicated in GBS adherence to host cells. It is also thought to play a role in immune evasion by binding to host antibodies and inhibiting complement activation.
C protein alpha-antigen
The C protein alpha-antigen is another surface protein that has been shown to be important for GBS colonization. It has been demonstrated to bind to components of the extracellular matrix and is required for efficient GBS invasion of host tissues.
C protein immunoglobulin-A-binding beta antigen
The C protein immunoglobulin-A-binding beta antigen is a surface protein that is thought to be involved in immune evasion. It has been shown to bind to secretory immunoglobulin A (IgA), a type of antibody found in mucosal secretions, and may prevent it from neutralizing GBS.
Immunodominant antigen A
The Immunodominant antigen A is a surface protein that is highly immunogenic, meaning that it elicits a strong immune response. It has been proposed as a potential vaccine candidate due to its ability to induce protective antibodies.
Pneumococcal vaccine antigen A
The Pneumococcal vaccine antigen A is a protein that is also found in Streptococcus pneumoniae, another common cause of bacterial infections. It has been included in some pneumococcal vaccines and may provide cross-protection against GBS.
67 kDa myosin-cross-reactive streptococcal antigen
The 67 kDa myosin-cross-reactive streptococcal antigen is a protein that shares a similar structure to a protein found in human heart muscle. Antibodies against this protein may cross-react with the human protein, leading to autoimmune heart disease in some individuals.
Serotype Ia IgA-binding beta antigen
The serotype Ia IgA-binding beta antigen is a surface protein that is specific to a particular strain of GBS (serotype Ia). It has been shown to bind to secretory IgA and may play a role in GBS pathogenesis.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple